Literature DB >> 17105377

Chromatin modification and muscle differentiation.

Hakima Yahi1, Ophélie Philipot, Valentina Guasconi, Lauriane Fritsch, Slimane Ait-Si-Ali.   

Abstract

Skeletal muscle differentiation is a multistep process, which begins with the commitment of multi-potent mesodermal precursor cells to the muscle fate. These committed cells, the myoblasts, then differentiate and fuse into multinucleated myotubes. The final step of muscle differentiation is the maturation of differentiated myotubes into myofibres. Skeletal muscle development requires the coordinated expression of various transcription factors like the members of the myocyte enhancer binding-factor 2 family and the muscle regulatory factors. These transcription factors, in collaboration with chromatin-remodelling complexes, act in specific combinations and within complex transcriptional regulatory networks to achieve skeletal myogenesis. Additional factors involved in the epigenetic regulation of this process continue to be discovered. In this review, the authors discuss the recent discoveries in the epigenetic regulation of myogenesis. They also summarise the role of chromatin-modifying enzymes regulating muscle gene expression. These different factors are often involved in multiple steps of muscle differentiation and have redundant activities. Altogether, the recent findings have allowed a better understanding of myogenesis and have raised new hopes for the pharmacological development of new therapies aimed at muscle degeneration diseases, such as myotonic dystrophy or Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105377     DOI: 10.1517/14728222.10.6.923

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  9 in total

1.  Systematic Analysis of Known and Candidate Lysine Demethylases in the Regulation of Myoblast Differentiation.

Authors:  Yoichi Munehira; Ze Yang; Or Gozani
Journal:  J Mol Biol       Date:  2016-10-11       Impact factor: 5.469

2.  Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry.

Authors:  Ekaterina Boyarchuk; Philippe Robin; Lauriane Fritsch; Véronique Joliot; Slimane Ait-Si-Ali
Journal:  J Vis Exp       Date:  2016-05-17       Impact factor: 1.355

3.  Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

Authors:  Laetitia P L Pelascini; Josephine M Janssen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther       Date:  2012-12-11       Impact factor: 5.695

Review 4.  MiRNAs, epigenetics, and cancer.

Authors:  Arefeh Rouhi; Dixie L Mager; R Keith Humphries; Florian Kuchenbauer
Journal:  Mamm Genome       Date:  2008-08-08       Impact factor: 2.957

5.  MyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structure.

Authors:  Anna Busanello; Cecilia Battistelli; Mariarosaria Carbone; Cassandra Mostocotto; Rossella Maione
Journal:  Nucleic Acids Res       Date:  2012-06-26       Impact factor: 16.971

6.  Methylation muscles into transcription factor silencing.

Authors:  Narendra Bharathy; Reshma Taneja
Journal:  Transcription       Date:  2012-09-01

7.  The methyltransferases PRMT4/CARM1 and PRMT5 control differentially myogenesis in zebrafish.

Authors:  Julie Batut; Carine Duboé; Laurence Vandel
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

8.  CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.

Authors:  Lucas Fauquier; Karim Azzag; Marco Antonio Mendoza Parra; Aurélie Quillien; Manon Boulet; Sarah Diouf; Gilles Carnac; Lucas Waltzer; Hinrich Gronemeyer; Laurence Vandel
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

Review 9.  Mesenchymal stem cell differentiation and usage for biotechnology applications: tissue engineering and food manufacturing.

Authors:  Dafna Benayahu
Journal:  Biomater Transl       Date:  2022-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.